Compare IMRX & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMRX | ALTI |
|---|---|---|
| Founded | 2008 | 2020 |
| Country | United States | United States |
| Employees | N/A | 490 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.7M | 407.2M |
| IPO Year | 2021 | 2021 |
| Metric | IMRX | ALTI |
|---|---|---|
| Price | $5.37 | $3.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $17.20 | N/A |
| AVG Volume (30 Days) | ★ 737.9K | 150.3K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.75 | ★ 41.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $254,956,000.00 |
| Revenue This Year | N/A | $18.06 |
| Revenue Next Year | N/A | $10.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 23.21 |
| 52 Week Low | $1.40 | $2.96 |
| 52 Week High | $10.08 | $5.45 |
| Indicator | IMRX | ALTI |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 35.75 |
| Support Level | $5.31 | $2.96 |
| Resistance Level | $5.80 | $3.96 |
| Average True Range (ATR) | 0.31 | 0.24 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 28.99 | 4.13 |
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.